GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Inventory-to-Revenue

LSB (LakeShore Biopharma Co) Inventory-to-Revenue : 2.06 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LakeShore Biopharma Co's Average Total Inventories for the quarter that ended in Sep. 2023 was $27.31 Mil. LakeShore Biopharma Co's Revenue for the three months ended in Sep. 2023 was $13.27 Mil. LakeShore Biopharma Co's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 2.06.

LakeShore Biopharma Co's Inventory-to-Revenue for the quarter that ended in Sep. 2023 increased from Jun. 2023 (1.06) to Jun. 2023 (2.06)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LakeShore Biopharma Co's Days Inventory for the three months ended in Sep. 2023 was 1,038.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. LakeShore Biopharma Co's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.09.


LakeShore Biopharma Co Inventory-to-Revenue Historical Data

The historical data trend for LakeShore Biopharma Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Inventory-to-Revenue Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Inventory-to-Revenue
0.32 0.24 0.27 0.35

LakeShore Biopharma Co Quarterly Data
Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only 0.83 - 1.06 2.06 -

Competitive Comparison of LakeShore Biopharma Co's Inventory-to-Revenue

For the Biotechnology subindustry, LakeShore Biopharma Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Inventory-to-Revenue falls into.



LakeShore Biopharma Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LakeShore Biopharma Co's Inventory-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Inventory-to-Revenue (A: Mar. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Mar. 2023 ) + Total Inventories (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )
=( (26.902 + 28.247) / 2 ) / 79.625
=27.5745 / 79.625
=0.35

LakeShore Biopharma Co's Inventory-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue (Q: Sep. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Jun. 2023 ) + Total Inventories (Q: Sep. 2023 )) / count ) / Revenue (Q: Sep. 2023 )
=( (25.466 + 29.162) / 2 ) / 13.267
=27.314 / 13.267
=2.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co  (NAS:LSB) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LakeShore Biopharma Co's Days Inventory for the three months ended in Sep. 2023 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2023 )/Cost of Goods Sold (Q: Sep. 2023 )*Days in Period
=27.314/2.399*365 / 4
=1,038.93

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LakeShore Biopharma Co's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2023 ) / Average Total Inventories (Q: Sep. 2023 )
=2.399 / 27.314
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LakeShore Biopharma Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.